Rhenman & Partners Asset Management AB as of Dec. 31, 2017
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 95 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 3.9 | $29M | 2.0M | 14.60 | |
| Esperion Therapeutics (ESPR) | 3.4 | $26M | 387k | 65.84 | |
| Adamas Pharmaceuticals | 3.2 | $24M | 693k | 33.89 | |
| Exelixis (EXEL) | 3.1 | $23M | 756k | 30.40 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.1 | $23M | 152k | 149.86 | |
| Nektar Therapeutics (NKTR) | 2.9 | $21M | 354k | 59.72 | |
| Gilead Sciences (GILD) | 2.8 | $21M | 286k | 71.64 | |
| Alexion Pharmaceuticals | 2.5 | $18M | 152k | 119.59 | |
| Jazz Pharmaceuticals (JAZZ) | 2.4 | $18M | 133k | 134.65 | |
| Sage Therapeutics (SAGE) | 2.3 | $17M | 105k | 164.71 | |
| Celgene Corporation | 2.3 | $17M | 161k | 104.36 | |
| UnitedHealth (UNH) | 2.2 | $17M | 76k | 220.46 | |
| Express Scripts Holding | 2.2 | $17M | 222k | 74.64 | |
| Abiomed | 2.2 | $16M | 87k | 187.41 | |
| AmerisourceBergen (COR) | 2.2 | $16M | 174k | 91.82 | |
| Intra Cellular Therapies (ITCI) | 2.1 | $16M | 1.1M | 14.48 | |
| Glaukos (GKOS) | 2.1 | $16M | 608k | 25.65 | |
| Incyte Corporation (INCY) | 2.1 | $16M | 164k | 94.71 | |
| Abbvie (ABBV) | 2.0 | $15M | 157k | 96.71 | |
| Humana (HUM) | 1.9 | $14M | 58k | 248.07 | |
| Medtronic (MDT) | 1.8 | $13M | 164k | 80.75 | |
| Arena Pharmaceuticals | 1.8 | $13M | 386k | 33.97 | |
| BioMarin Pharmaceutical (BMRN) | 1.7 | $13M | 140k | 89.17 | |
| Eli Lilly & Co. (LLY) | 1.6 | $12M | 143k | 84.46 | |
| Regeneron Pharmaceuticals (REGN) | 1.6 | $12M | 31k | 375.97 | |
| Portola Pharmaceuticals | 1.4 | $10M | 211k | 48.68 | |
| ACADIA Pharmaceuticals (ACAD) | 1.4 | $10M | 339k | 30.11 | |
| Allergan | 1.3 | $9.7M | 59k | 163.58 | |
| Novocure Ltd ord (NVCR) | 1.3 | $9.4M | 468k | 20.20 | |
| CIGNA Corporation | 1.2 | $9.2M | 45k | 203.08 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $9.2M | 118k | 77.59 | |
| Boston Scientific Corporation (BSX) | 1.2 | $8.6M | 348k | 24.79 | |
| Edwards Lifesciences (EW) | 1.1 | $8.3M | 73k | 112.71 | |
| Fibrogen (FGEN) | 1.1 | $8.0M | 170k | 47.40 | |
| Bristol Myers Squibb (BMY) | 1.1 | $8.0M | 130k | 61.28 | |
| Immunomedics | 1.1 | $7.8M | 480k | 16.16 | |
| Loxo Oncology | 1.0 | $7.6M | 90k | 84.18 | |
| Aerie Pharmaceuticals | 1.0 | $7.6M | 127k | 59.75 | |
| Iovance Biotherapeutics (IOVA) | 1.0 | $7.6M | 944k | 8.00 | |
| Rigel Pharmaceuticals (RIGL) | 1.0 | $7.5M | 1.9M | 3.88 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $7.5M | 59k | 127.05 | |
| Myokardia | 1.0 | $7.5M | 178k | 42.10 | |
| Abbott Laboratories (ABT) | 0.9 | $7.0M | 122k | 57.07 | |
| Xencor (XNCR) | 0.9 | $7.0M | 318k | 21.92 | |
| Anthem (ELV) | 0.9 | $7.0M | 31k | 225.00 | |
| Flexion Therapeutics | 0.9 | $6.6M | 262k | 25.04 | |
| Revance Therapeutics (RVNC) | 0.9 | $6.5M | 183k | 35.75 | |
| Array BioPharma | 0.9 | $6.4M | 503k | 12.80 | |
| Universal Health Services (UHS) | 0.8 | $5.9M | 52k | 113.34 | |
| Macrogenics (MGNX) | 0.8 | $5.9M | 309k | 19.00 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $5.7M | 100k | 57.17 | |
| Hca Holdings (HCA) | 0.7 | $5.2M | 59k | 87.85 | |
| Endologix | 0.7 | $5.1M | 956k | 5.35 | |
| Juno Therapeutics | 0.7 | $5.0M | 109k | 45.71 | |
| Puma Biotechnology (PBYI) | 0.7 | $4.9M | 50k | 98.86 | |
| Biogen Idec (BIIB) | 0.7 | $4.9M | 15k | 318.56 | |
| Walgreen Boots Alliance (WBA) | 0.6 | $4.8M | 66k | 72.62 | |
| Centene Corporation (CNC) | 0.6 | $4.5M | 45k | 100.89 | |
| Dynavax Technologies (DVAX) | 0.6 | $4.5M | 243k | 18.70 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $4.4M | 95k | 46.38 | |
| Sangamo Biosciences (SGMO) | 0.6 | $4.2M | 256k | 16.40 | |
| Livanova Plc Ord (LIVN) | 0.6 | $4.2M | 53k | 79.92 | |
| Dex (DXCM) | 0.6 | $4.1M | 71k | 57.39 | |
| Spark Therapeutics | 0.5 | $3.6M | 70k | 51.42 | |
| Alkermes (ALKS) | 0.4 | $3.2M | 59k | 54.73 | |
| Coherus Biosciences (CHRS) | 0.4 | $3.1M | 350k | 8.80 | |
| Omnicell (OMCL) | 0.4 | $2.8M | 58k | 48.51 | |
| Epizyme | 0.4 | $2.7M | 218k | 12.55 | |
| Dermira | 0.4 | $2.6M | 95k | 27.81 | |
| Viewray (VRAYQ) | 0.3 | $2.6M | 282k | 9.26 | |
| Intercept Pharmaceuticals In | 0.3 | $2.2M | 39k | 58.42 | |
| Zogenix | 0.3 | $2.1M | 52k | 40.05 | |
| Achillion Pharmaceuticals | 0.3 | $1.9M | 668k | 2.88 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $1.7M | 450k | 3.69 | |
| Chimerix (CMRX) | 0.2 | $1.6M | 342k | 4.63 | |
| Newlink Genetics Corporation | 0.2 | $1.5M | 181k | 8.11 | |
| Keryx Biopharmaceuticals | 0.2 | $1.4M | 302k | 4.65 | |
| STAAR Surgical Company (STAA) | 0.2 | $1.2M | 76k | 15.50 | |
| Tetraphase Pharmaceuticals | 0.1 | $1.0M | 161k | 6.30 | |
| Nevro (NVRO) | 0.1 | $1.0M | 15k | 69.07 | |
| Ra Pharmaceuticals | 0.1 | $922k | 109k | 8.50 | |
| JPMorgan Chase & Co. (JPM) | 0.1 | $483k | 4.5k | 106.91 | |
| Halliburton Company (HAL) | 0.1 | $545k | 11k | 48.91 | |
| Regulus Therapeutics | 0.1 | $513k | 493k | 1.04 | |
| Microsoft Corporation (MSFT) | 0.1 | $410k | 4.8k | 85.54 | |
| Exxon Mobil Corporation (XOM) | 0.1 | $476k | 5.7k | 83.57 | |
| Wells Fargo & Company (WFC) | 0.1 | $463k | 7.6k | 60.64 | |
| Adverum Biotechnologies | 0.1 | $445k | 127k | 3.50 | |
| Janus Henderson Group Plc Ord (JHG) | 0.1 | $456k | 12k | 38.30 | |
| Pfizer (PFE) | 0.1 | $377k | 10k | 36.17 | |
| Qualcomm (QCOM) | 0.1 | $344k | 5.4k | 64.08 | |
| Ford Motor Company (F) | 0.1 | $355k | 28k | 12.50 | |
| International Business Machines (IBM) | 0.0 | $271k | 1.8k | 153.45 | |
| Symantec Corporation | 0.0 | $263k | 9.4k | 28.10 | |
| Anheuser-Busch InBev NV (BUD) | 0.0 | $313k | 2.8k | 111.55 |
